Improved guideline adherence may not overcome evidence gaps in severe trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia infection: a case-based perspective

Key Points

• Improved guideline adherence may not significantly change outcomes in resistant infections.
• Trimethoprim-sulfamethoxazole resistance is noted in serious Stenotrophomonas maltophilia cases.
• Observational analysis focused on case-based perspectives to identify evidence gaps.
• The findings highlight the need for updated guidelines and further investigation into treatment options.